美国医疗保健技术公司Evolent Health（股票代码：EVH）今日盘前大跌5.05%，主要原因是公司最新公布的季度业绩远低于市场预期。
根据公司发布的财报，截至6月30日的季度，Evolent Health调整后每股亏损0.10美元，而去年同期为每股盈利0.30美元。这一业绩显著低于分析师平均预期的每股盈利0.08美元。同时，公司季度营收同比下降31.3%至4.4433亿美元，也未能达到分析师预期的4.5942亿美元。更值得注意的是，公司本季度净亏损高达5109万美元。
值得关注的是，这已经是Evolent Health连续第四个季度未能达到盈利预期，这可能引发投资者对公司长期增长前景的担忧。尽管如此，分析师对该公司的平均评级仍维持在"买入"，12个月目标价中位数为16.00美元，较最新收盘价高出约39.4%。然而，考虑到公司今年以来的股价已下跌16.4%，投资者可能需要重新评估其投资策略。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.